RecruitingNCT04028219

Transgender In Transition

Transgender In Transition: Metabolism, Behaviour and Psychopathology in Transsexual Patients Following Hormonal Treatment

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Enrollment

750 participants

Start Date

May 15, 2019

Study Type

OBSERVATIONAL

Conditions

Gender Incongruence

Summary

Prospective trial in gender dysphoric patients who undergo gender-affirming hormone therapy, aiming to investigate psychological, biological and behavioural consequences of hormonal therapy.

Eligibility

Min Age: 18 Years

Inclusion Criteria3

diagnosis of gender incongruence (ICD-11) or gender dysphoria (DSM-5)
written informed consent following adequate oral and written Information
before gender-affirming hormonal treatment

Exclusion Criteria1

pregnancy or breast-feeding

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTOnline surveys

Psychometric measures within 14 online surveys, which is one at each assessment point (before and 3, 6, 9, 12, 24, 36, 48, 60, 72, 84, 96, 108, 120 months after hormonal therapy).

Locations(5)

Universitätsklinikum Frankfurt

Frankfurt am Main, Hesse, Germany

University Medical Center Hamburg-Eppendorf

Hamburg, Germany

Medical Center of the Ludwig-Maximilians-University of Munich

Munich, Germany

Universitätsspital Basel

Basel, Switzerland

UniversitätsSpital Zürich

Zurich, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04028219

Related Trials

Cardiovascular Health of Transgender Individuals During the Gender-affirming Pathway

NCT071879471 location